Davis Andrew
- SEC CIK
- 0001932525
No open-market purchases or sales filed in the past year.
Current role at each company
- IRWD Ironwood Pharmaceuticals IncSVP, Chief Business Officeras of Nov 20, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Davis Andrew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2024 (view filing) | Nov 18 | 2 days | Davis AndrewSVP, Chief Business Officer | SSaleClass A Common Stock | −5.36K | $4.08 | −$21.9K | −1.8%284.7K after | |
| May 22, 2024 (view filing) | May 20 | 2 days | Davis AndrewSVP, Chief Business Officer | SSaleClass A Common Stock | −22.7K | $6.45 | −$146.6K | −7.3%288.0K after | |
| Feb 14, 2024 (view filing) | Feb 12 | 2 days | Davis AndrewSVP, Chief Business Officer | SSaleClass A Common Stock | −9.85K | $15.24 | −$150.1K | −4.5%208.3K after | |
| Nov 22, 2023 (view filing) | Nov 20 | 2 days | Davis AndrewSVP, Chief Business Officer | SSaleClass A Common Stock | −3.29K | $9.69 | −$31.9K | −1.5%217.4K after | |
| May 24, 2023 (view filing) | May 22 | 2 days | Davis AndrewSVP, Chief Business Officer | SSaleClass A Common Stock | −6.30K | $10.12 | −$63.8K | −2.8%219.3K after | |
| Mar 1, 2023 (view filing) | Feb 27-28 | 2 days | Davis AndrewSVP, Chief Business Officer | SSaleClass A Common Stock | −3.57K | $11.36 | −$40.6K | −2.3%151.4K after | 2 lots |
| Nov 23, 2022 (view filing) | Nov 21 | 2 days | Davis AndrewSVP, Chief Business Officer | SSaleClass A Common Stock | −3.33K | $11.56 | −$38.6K | −2.1%154.2K after |